| 171 |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
|
قسم الاورام الطبية |
2021 |
| 172 |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
|
قسم الباثولولجيا الاكلينيكية |
2021 |
| 173 |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
|
قسم الباثولولجيا الاكلينيكية |
2021 |
| 174 |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
|
قسم الاورام الطبية |
2021 |
| 175 |
HLA-B* 15 predicts survival in Egyptian patients with COVID-19 |
قسم الباثولولجيا الاكلينيكية |
2021 |
| 176 |
Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia |
قسم أورام الأطفال |
2021 |
| 177 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
قسم الباثولولجيا الاكلينيكية |
2021 |
| 178 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
قسم الاورام الطبية |
2021 |
| 179 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
قسم الباثولولجيا الاكلينيكية |
2021 |
| 180 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
قسم الباثولولجيا الاكلينيكية |
2021 |
